ClinicalTrials.gg
Sign In

Leukemia, Myeloid, Chronic-Phase clinical trials

The registry lists 439 studies for Leukemia, Myeloid, Chronic-Phase across more than 10 countries. 27 are recruiting or about to start. 61 of them are mainly about Leukemia, Myeloid, Chronic-Phase (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Leukemia, Myeloid, Chronic-Phase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
272
Terminated
69
Status unknown
32
Active, not recruiting
21
Recruiting
20
Withdrawn
17

Phase

Phase 2
210
Phase 1
108
Phase 3
58
Phase 4
8
Early Phase 1
1

Where

United States
338
Italy
29
Germany
26
France
26
Canada
17
United Kingdom
17

Who runs them

Fred Hutchinson Cancer Center (45) · M.D. Anderson Cancer Center (26) · National Cancer Institute (NCI) (18) · City of Hope Medical Center (18) · Memorial Sloan Kettering Cancer Center (15) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (14) · Roswell Park Cancer Institute (13) · OHSU Knight Cancer Institute (12)

What is being tested here

Drugs under test in Leukemia, Myeloid, Chronic-Phase studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Asciminib316
Flumatinib304
Relcobatinib313
Embibatinib303
Ponatinib216
Cyclophosphamide1148
Busulfan1133
Dasatinib1424
Melphalan1114
Nilotinib1114

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 15 open · Alkylating agents 1 open · Antimetabolites 1 open · Calcineurin inhibitors 34 · Corticosteroids 13

Coming up

5phase 3 studies under way
7studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7, phase 3 first

Who these studies take

Of the 20 Leukemia, Myeloid, Chronic-Phase studies recruiting now, 13 (65%) set no upper age limit and 5 (25%) stop at 75 or younger. 3 (15%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (5%) take healthy volunteers.

Recruiting studies that take each age, of 20
AgeWomenMen
102 (10%)2 (10%)
1817 (85%)17 (85%)
3017 (85%)17 (85%)
4017 (85%)17 (85%)
5017 (85%)17 (85%)
6518 (90%)18 (90%)
7516 (80%)16 (80%)
8514 (70%)14 (70%)

Across all 439 studies, recruiting or not: 38% stop at 75 or younger and 25% at 65; 43% take children; 0% are for women only and <1% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Leukemia, Myeloid, Chronic-Phase studies take

Of 49 phase 2 interventional studies under Leukemia, Myeloid, Chronic-Phase, half reached primary completion within 70 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 270 mo43–132 · 49 studies—84 mo44–153 · 42 studies
Observational35 mo31–59 · 13 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 439. Browse all 439 → or search them.